United States · 
What does Myeloma Investment Fund invest in?
Myeloma Investment Fund invests most often at Seed (100% of the rounds on record), in sectors such as Multiple Myeloma, Biotech and Therapeutics.
Myeloma Investment Fund highlights
- 01
1 rounds on record
- 02
Mostly Seed: 100% of its rounds
What they do
The Myeloma Investment Fund invests in companies developing innovative therapies and technologies with potential to transform myeloma patient outcomes.From their own website
- Type
- Corporate VC (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries B
- Sectors
- Multiple MyelomaBiotechTherapeutics
- Based in
- Brookline, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2025
1 round
- Feb
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 6 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
10 of 14 we have independently watched raise
AbcuroCoding BioEnvisagenicsIndapta TherapeuticsOpna BioSanofiStylus MedicineTelo TherapeuticsTriumvira ImmunologicsUmoja BiopharmaCytoImmune TherapeuticsKahrOnline FormTRIO Pharmaceuticals
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.